AzTrials
AzTrials

SuicideSP-BSCNCT07125144

Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago

A study testing Black Youth Suicide Prevention in Chicago and Signs of Suicide: Standard/Existing in people with Suicide and Suicidal Ideation, run by University of Chicago at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Suicide has been the third leading cause of death for Black youth in the U.S since the 1980s and persists as a leading cause of death for Black youth today. For example, in 2018 suicide was reported as the 2nd leading cause of death among Black Americans ages 10 to14 years old. Read more about this study

Who is it for?
Ages 11 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Suicide, Suicidal Ideation, Suicide Attempt
What is being tested?
Black Youth Suicide Prevention in Chicago and Signs of Suicide: Standard/Existing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
30 Jan 2025to 31 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Enrolled in 6th, 7th, or 8th grade at a participating school

Who cannot join

  • Not enrolled in 6th, 7th, or 8th grade at a participating school

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Janelle R Goodwill, PhD contact

773-834-5114

jgoodwill@uchicago.edu

Miwa Yasui, PhD contact

773-702-5187

myasui@uchicago.edu

United States1 site, 1 recruiting
  • University of Chicago

    Chicago, Illinois, 60637

    Recruiting

Other trials in United States

About this study

Official title: Piloting a Culturally Adapted Multilevel Suicide Prevention Intervention in Schools for Black Youth and Their Families

Suicide has been the third leading cause of death for Black youth in the U.S since the 1980s and persists as a leading cause of death for Black youth today. For example, in 2018 suicide was reported as the 2nd leading cause of death among Black Americans ages 10 to14 years old. Findings yielded from recent queries indicate that the gap in suicides among Black males and female youth has narrowed in recent years. Despite these disturbing trends, a dearth persists in our understanding of the factors that contribute to and prevent against suicide in Black youth, thus diminishing researchers' ability to effectively detect suicide risk in this particular population. This project aims to redress this gap by proposing the cultural adaptation of an existing suicide prevention intervention, the Signs of Suicide (SOS) prevention program, for Black middle school students. Our team will conduct a pilot randomized controlled trial among a sample of Black middle school students to assess feasibility and

examine underlying mechanisms that contribute to suicidality among Black youth. Intervention content will be adapted to assess how topics of racial identity, racial socialization, and racial discrimination uniquely impact Black youth's mental health experiences and risk for suicide. Measures of suicidal ideation, planning, and attempt will be assessed at pre-test, post-test, and 3-months after the intervention. Findings derived from this project will contribute to public health priorities by offering unique insight into the factors that either prevent or promote suicide among Black youth and could be replicated in other schools serving Black students across the nation.

Being tested
Black Youth Suicide Prevention in Chicago, Signs of Suicide: Standard/Existing
Keywords
Black, youth, suicide, suicide prevention, intervention, Signs of Suicide, Cultural Adaptation, Chicago, African American, Adolescent
Medical subject headings
Suicide, Suicidal Ideation, Suicide, Attempted, Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Black Youth Suicide Prevention in ChicagoBehavioural

    The Culturally Adapted intervention uses intervention video content that specifically addresses topics that shape Black youth's psychological wellbeing and development. The goal of this intervention is to share suicide prevention information in ways that are culturally responsive and attentive to the specific needs of Black adolescents.

  • Signs of Suicide: Standard/ExistingBehavioural

    Students attending schools assigned to the Standard/Existing Intervention condition will receive the Signs of Suicide curriculum.

Study groups in NCT07125144
Study groupRoleWhat they receive
Standard/Existing InterventionActive comparatorStudents attending schools assigned to the Standard/Existing Intervention condition will receive the existing Signs of Suicide intervention.
Receives: Behavioral: Signs of Suicide: Standard/Existing
Culturally Adapted InterventionExperimentalStudents attending schools assigned to the Culturally Adapted Intervention condition will receive a new culturally adapted intervention developed for this study.
Receives: Behavioral: Black Youth Suicide Prevention in Chicago

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suicidal Ideation

    Item that asks students to report if they have seriously considered suicide

    Measured: Baseline, 2 weeks after baseline, 3-months after baseline

Secondary outcomes (3)
  1. Suicide Attempt

    Item that asks students to report if they have attempted suicide.

    Measured: Baseline, 2 weeks after baseline, 3-months after baseline

  2. Knowledge of Depression and Suicide

    This scale includes items that assess students' knowledge of depression and suicide risk and warning signs. This is the title of the scale, as used and reported in earlier suicide prevention interventions (Aseltine \& DeMartino, 2004; Schilling et al., 2016). Responses are collected using a list of true/false options. The total number of "true" statements represents more accurate knowledge of depression and suicide risk warning signs.

    Measured: Baseline, 2 weeks after baseline, 3-months after baseline

  3. Attitudes Towards Depression and Suicide

    This scale includes Items that assess students' attitudes towards depression and suicide. This is the title of the scale, as used and reported in earlier suicide prevention interventions (Aseltine \& DeMartino, 2004; Schilling et al., 2016). The measure includes a 5-point Likert scale with responses ranging from 1 = "Strongly Disagree" to 5 = "Strongly Agree." Higher scores on this scale represent more adaptive attitudes towards depression and suicide risk.

    Measured: Baseline, 2 weeks after baseline, 3-months after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2025
  2. Study start30 Jan 2025
  3. Primary completion31 Mar 2026 (estimated)
  4. Study completion31 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07125144
Sponsor's protocol ID
R34MH129789
Other IDs
R34MH129789
Acronym
SP-BSC
Status last verified
Aug 2025
First submitted
4 Aug 2025
Last updated
15 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Specific data describing participants grade level and scores on primary outcome measures will be made available, per NIMH Data Archive guidelines.

Questions about this trial

What is this clinical trial studying?

A study testing Black Youth Suicide Prevention in Chicago and Signs of Suicide: Standard/Existing in people with Suicide and Suicidal Ideation, run by University of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Janelle R Goodwill, PhD (773-834-5114, jgoodwill@uchicago.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Suicidal Ideation (time frame: Baseline, 2 weeks after baseline, 3-months after baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in